Paclitaxel Protein-Bound Injection Shortage
Last Updated: April 28, 2023
Status: Current
Products Affected - Description
-
- Paclitaxel protein-bound intravenous lyophilized powder for injection, Apotex, 100 mg, vial, NDC 60505-6230-04 - discontinued
- Paclitaxel protein-bound intravenous lyophilized powder for injection, TWi Pharmaceuticals, 100 mg, vial, NDC 24979-0710-51 - discontinued
Reason for the Shortage
-
- Apotex and TWI products were authorized generics. Bristol Myers Squibb is no longer providing authorized generics.
- Bristol Myers Squibb has Abraxane injection available.
Available Products
-
- Abraxane intravenous lyophilized powder for injection, Bristol-Myers Squibb, 100 mg, vial, NDC 68817-0134-50
Updated
Updated April 28, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 27, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.